TFG Asset Management GP Ltd - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is and the CUSIP is 528872AB0. A total of 5 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TFG Asset Management GP Ltd ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$5,331,000
+1.4%
5,250,0000.0%0.33%
+13.9%
Q2 2021$5,259,000
-9.4%
5,250,0000.0%0.29%
-30.8%
Q1 2021$5,802,000
+31.6%
5,250,0000.0%0.42%
+40.2%
Q4 2020$4,410,000
+4.8%
5,250,0000.0%0.30%
-23.3%
Q3 2020$4,207,000
-43.0%
5,250,000
-63.8%
0.39%
-60.8%
Q2 2020$7,387,000
-0.9%
14,500,0000.0%0.98%
-23.7%
Q1 2020$7,456,000
-33.6%
14,500,0000.0%1.29%
-22.7%
Q4 2019$11,233,000
+17.8%
14,500,0000.0%1.67%
-1.9%
Q3 2019$9,538,000
-40.0%
14,500,0000.0%1.70%
-26.3%
Q2 2019$15,905,000
+5.7%
14,500,0000.0%2.31%
+23.4%
Q1 2019$15,044,000
-7.2%
14,500,0000.0%1.87%
-26.8%
Q4 2018$16,211,000
-25.6%
14,500,0000.0%2.56%
-1.9%
Q3 2018$21,776,000
-7.0%
14,500,0000.0%2.61%
-18.7%
Q2 2018$23,419,000
+22.7%
14,500,0000.0%3.20%
+8.5%
Q1 2018$19,079,000
-23.4%
14,500,000
-17.1%
2.95%
-21.9%
Q4 2017$24,918,000
-15.2%
17,500,0000.0%3.78%
-20.7%
Q3 2017$29,386,000
-19.7%
17,500,0000.0%4.77%
-12.4%
Q2 2017$36,587,000
+11.6%
17,500,0000.0%5.44%
-11.5%
Q1 2017$32,791,000
+4.1%
17,500,0000.0%6.15%
-1.7%
Q4 2016$31,512,000
-21.0%
17,500,0000.0%6.26%
-17.1%
Q3 2016$39,872,000
+40.6%
17,500,000
+16.7%
7.55%
+16.9%
Q2 2016$28,351,000
+169.0%
15,000,000
+130.8%
6.46%
+93.2%
Q1 2016$10,540,000
+19.3%
6,500,000
+30.0%
3.34%
-96.5%
Q4 2015$8,834,0005,000,00095.58%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 14,500,000$15,044,0001.87%
WOLVERINE ASSET MANAGEMENT LLC 12,250,000$12,530,0000.17%
DeepCurrents Investment Group LLC 1,000,000$1,107,0000.10%
Verition Fund Management LLC 709,000$716,0000.03%
LAZARD ASSET MANAGEMENT LLC 10,000,000$10,105,0000.02%
Citadel Advisors 31,800,000$32,140,0000.02%
UBS ASSET MANAGEMENT AMERICAS INC 10,500,000$10,735,200,0000.01%
DEUTSCHE BANK AG\ 4,500,000$4,525,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 2,500,000$2,513,0000.00%
MACKAY SHIELDS LLC 157,000$159,0000.00%
View complete list of LEXICON PHARMACEUTICALS INC shareholders